-
5
-
-
0034619028
-
Adverse drug reactions: Definitions, diagnosis, and management
-
Edwards IR., Aronson JK Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9
-
(2000)
Lancet
, vol.356
, pp. 1255-1259
-
-
Edwards, I.R.1
Aronson, J.K.2
-
7
-
-
0022036232
-
Imputabilité des effets inattendus ou toxiques des médicaments
-
Begaud B, Evreux JC, Jouglard J et al,. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985; 40: 111-8
-
(1985)
Thérapie
, vol.40
, pp. 111-118
-
-
Begaud, B.1
Evreux, J.C.2
Jouglard, J.3
-
8
-
-
0025375133
-
Assessment of current diagnostic criteria for Guillain-Barré syndrome
-
Asbury A, Cornblath D. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27: S21-S24
-
(1990)
Ann Neurol
, vol.27
-
-
Asbury, A.1
Cornblath, D.2
-
11
-
-
38449106598
-
Quelle pharmacovigilance pour les vaccins
-
Le Louët H, Loupi E, Haramburu F. Quelle pharmacovigilance pour les vaccins. Thérapie 2007; 62: 241-4
-
(2007)
Thérapie
, vol.62
, pp. 241-244
-
-
Le Louët, H.1
Loupi, E.2
Haramburu, F.3
-
12
-
-
3442895007
-
Pharmacovigilance des vaccins contre l'hépatite B
-
Imbs JL, Decker N, Welsch M et al., Pharmacovigilance des vaccins contre l'hépatite B. Discussion: les vaccinations. Bull Acad Natl Med 2003; 187 (n° 8): 1489-500 (Pubitemid 39005352)
-
(2003)
Bulletin de l'Academie Nationale de Medecine
, vol.187
, Issue.8
, pp. 1489-1500
-
-
Imbs, J.-L.1
Decker, N.2
Welsch, M.3
Aron, E.4
Sraer, J.D.5
Blancher, G.6
Arthuis, M.7
-
13
-
-
78649673051
-
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: Results of a national vaccination campaign
-
Bone A, Guthmann JP, Nicolau J et al,. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 2010; 28: 8157-61
-
(2010)
Vaccine
, vol.28
, pp. 8157-8161
-
-
Bone, A.1
Guthmann, J.P.2
Nicolau, J.3
-
15
-
-
61549116834
-
Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
-
Vellozzi C, Burwen DR, Dobardzic A et al,. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009; 27: 2114-20
-
(2009)
Vaccine
, vol.27
, pp. 2114-2120
-
-
Vellozzi, C.1
Burwen, D.R.2
Dobardzic, A.3
-
17
-
-
65949102549
-
Vaccines and Guillain-Barre syndrome
-
Haber P, Sejvar J, Mikaeloff Y et al,. Vaccines and Guillain-Barre syndrome. Drug Saf 2009; 32: 309-23
-
(2009)
Drug Saf
, vol.32
, pp. 309-323
-
-
Haber, P.1
Sejvar, J.2
Mikaeloff, Y.3
-
18
-
-
72049119602
-
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
-
Black S, Eskola J, Siegrist CA. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. The Lancet 2009; 374: 2115-22
-
(2009)
The Lancet
, vol.374
, pp. 2115-2122
-
-
Black, S.1
Eskola, J.2
Siegrist, C.A.3
-
19
-
-
85031205713
-
Number of spontaneous reports of Guillain-Barré syndrome after flu A(H1N1) vaccination versus expected number in France
-
Saussier C, Hill C, Castot C. Number of spontaneous reports of Guillain-Barré syndrome after flu A(H1N1) vaccination versus expected number in France. Drug Saf 2010; 33: 10
-
(2010)
Drug Saf
, vol.33
, pp. 10
-
-
Saussier, C.1
Hill, C.2
Castot, C.3
-
20
-
-
70049100227
-
Epidemiology of multiple sclerosis: The special situation in France
-
Fromont A, Binquet C, Clerc L et al,. Epidemiology of multiple sclerosis: the special situation in France. Rev Neurol 2009; 165: 671-5
-
(2009)
Rev Neurol
, vol.165
, pp. 671-675
-
-
Fromont, A.1
Binquet, C.2
Clerc, L.3
-
21
-
-
63449125198
-
-
EURO-PERISTAT Project, with SCPE, EUROCAT, EURONEOSTAT
-
EURO-PERISTAT Project, with SCPE, EUROCAT, EURONEOSTAT. European Perinatal Health Report. 2008. http://www.europeristat.com
-
(2008)
European Perinatal Health Report
-
-
-
22
-
-
0036766299
-
La pharmacologie sociale: Une nouvelle branche de la pharmacologie clinique
-
Montastruc JL. Social pharmacology: a new topic in clinical pharmacology. Thérapie 2002; 57: 420-6 (Pubitemid 36070038)
-
(2002)
Therapie
, vol.57
, Issue.5
, pp. 420-426
-
-
Montastruc, J.L.1
-
23
-
-
21244506751
-
"Medicamentation" of society, non-diseases and non-medications: A point of view from social pharmacology
-
DOI 10.1007/s00228-005-0925-6
-
Mbongue TB, Sommet A, Pathak A et al,. « Medicamentation » of society, non-diseases and non-medications: a point of view from social pharmacology. Eur J Clin Pharmacol 2005; 61: 309-13 (Pubitemid 40884027)
-
(2005)
European Journal of Clinical Pharmacology
, vol.61
, Issue.4
, pp. 309-313
-
-
Ngoundo Mbongue, T.B.1
Sommet, A.2
Pathak, A.3
Montastruc, J.L.4
|